Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Edaravone (1.5mg) Injection
Therapeutic Category
Neurology
Dosage Form
Injection
Packaging Type
vial
Packaging
20 ml
Price
₹890/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Edavine Injection contains Edaravone, a potent free radical scavenger and antioxidant used primarily for its neuroprotective effects. It works by inhibiting oxidative stress and lipid peroxidation, which are major contributors to neuronal damage during ischemic and neurodegenerative processes. By reducing oxidative injury, Edavine helps preserve neuronal function and prevent secondary damage in acute ischemic stroke and certain neurodegenerative disorders. The injectable form allows rapid delivery to the systemic circulation, providing timely therapeutic action in critical care settings. Edaravone has also shown promise in managing amyotrophic lateral sclerosis (ALS) and other oxidative stress–related neurological conditions.
Common side effects include headache, dizziness, nausea, vomiting, and mild injection-site reactions. Some patients may experience rash, fever, or elevated liver enzymes. Rare but serious adverse reactions include hypersensitivity, acute renal failure, and anaphylactic shock. Monitoring of renal and hepatic function is recommended during therapy.
Edavine Injection is indicated for the treatment of acute ischemic stroke to improve functional recovery when administered within the therapeutic window. It is also used as part of supportive therapy in amyotrophic lateral sclerosis (ALS) and may be prescribed in other oxidative stress–mediated neurological conditions as per physician guidance.
Edavine Injection should be administered only under medical supervision in a hospital or clinical setting. It is contraindicated in patients with known hypersensitivity to Edaravone or any excipients. Caution is advised in patients with renal or hepatic impairment. The injection must be given as per recommended dosage and infusion rate; improper administration can lead to adverse effects. Not recommended during pregnancy or breastfeeding unless the potential benefits outweigh the risks. Regular monitoring of clinical and biochemical parameters is essential during treatment.
Store Edavine Injection at a temperature below 25°C, protected from light and moisture. Do not freeze. Keep in the original packaging and out of reach of children. Use immediately after opening and discard any unused portion to prevent contamination.
Composition : Cerebroprotein Hydrolysate (60mg)
Composition : Piracetam (200mg)
Composition : Piracetam I.P. 500mg Syrup
Composition : Citicoline (500mg) + Piracetam (800mg)
Composition : Citicoline (250mg) Injection
Composition : Citicoline (500mg) Tablet
Composition : Citicoline (500mg) + Piracetam (400mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Edavine Injection containing Edaravone 1.5mg is widely used in neurology and critical care management, making it a high-value specialty product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from demand in stroke management, neuroprotection therapy, oxidative stress reduction, and neurological care support. It is commonly prescribed in hospitals and specialty neurology settings for critical patient care.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Edavine Injection (Edaravone 1.5mg Injection) with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from specialty hospital demand, critical-care usage, and growing acceptance in neurology treatment segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this neurology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.